🇺🇸 FDA
Patent

US 9271950

Compositions for treating chronic inflammation and inflammatory diseases

granted A61KA61K31/19A61K31/192

Quick answer

US patent 9271950 (Compositions for treating chronic inflammation and inflammatory diseases) held by Infirst Healthcare Limited expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/202, A61K31/25